Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Cited by (1,001)

Items 901–1,000 of 1,001

1. Role of Snai2 and Notch signaling in salivary gland myoepithelial cell fate
   Rika Yasuhara, Seya Kang, Tarou Irié, Yo Mabuchi, Satoko Kujiraoka, Akane Yukimori, Shoko Ishida, Junichi Tanaka, Kenji Mishima · 2022 · Laboratory Investigation
2. Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development
   Kirsty R. Greenow, Matthew John Smalley · 2015 · Current Protocols in Pharmacology
3. Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors
   Hawley C. Pruitt, Brandon J. Metge, Shannon E. Weeks, Dongquan Chen, Shi Wei, Robert A. Kesterson, Lalita A. Shevde, Rajeev S. Samant · 2018 · Oncogene
4. Abstract 3328: Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
   Aleix Prat, Olga A. Karginova, Joel S. Parker, Cheng Fan, Xiaping He, Lisa M. Bixby, Erick Roman, Joshua Chuck Harrell, Melissa A. Troester, Charles M. Perou · 2011 · Cancer Research
5. A Human Breast Cell Atlas Mapping the Homeostatic Cellular Shifts in the Adult Breast
   Austin D. Reed, Sara Pensa, Adi Steif, Jack Stenning, Daniel J. Kunz, Peng He, Alecia‐Jane Twigger, Katarzyna Kania, Rachel Barrow‐McGee, Iain Goulding et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
6. Organoid Cultures for the Study of Mammary Biology and Breast Cancer: The Promise and Challenges
   Senthil K. Muthuswamy, Joan S. Brugge · 2023 · Cold Spring Harbor Perspectives in Medicine
7. Redefining normal breast cell populations using long noncoding RNAs
   Mainá Bitar, S. Rivera, Isabela Pimentel de Almeida, Wei Shi, Kaltin Ferguson, Jonathan Beesley, Sunil R. Lakhani, Stacey L. Edwards, Juliet D. French · 2023 · Nucleic Acids Research
8. Young Women with Breast Cancer: The Current Role of Precision Oncology
   Amirrtha Srikanthan, Arif Ali Awan, Sharon F. McGee, Moira Katherine Rushton · 2023 · Journal of Personalized Medicine
9. Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R Oncogene
   Poornima Bhat‐Nakshatri, Aditi Sanjay Khatpe, Duojiao Chen, Katie Batic, Henry Elmer Mang, Christopher Herodotou, Patrick C. McGuire, Xiaoling Xuei, Cihat Erdoğan, Hongyu Gao et al. · 2023 · Cancer Research Communications
10. High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals
    Kimberley E. Sala-Hamrick, Anagha Tapaswi, Katelyn M. Polemi, Vy Kim Nguyen, Justin A. Colacino · 2024 · Environmental Health Perspectives
11. Comprehensive identification, isolation, and culture of human breast cell types
    Kate Thi, Katelyn Del Toro, Yamhilette Licón-Muñoz, Rosalyn W. Sayaman, William Curtis Hines · 2024 · Journal of Biological Chemistry
12. Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models
    Sarmila Majumder, Sanjay Mishra, Neelam Shinde, Maria C. Cuitiño, Morgan Bauer, Dinesh Kumar Ahirwar, Mustafa M. Basree, Vijaya Bharti, Kate Ormiston, Resham Mawalkar et al. · 2025 · Breast Cancer Research
13. Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers
    Sarah C. Moser, Jos Jonkers · 2025 · Cancer Discovery
14. Segmented regression, a versatile tool to analyze mRNA levels in relation to DNA copy number aberrations
    Szilárd Nemes, Toshima Z. Parris, Anna Danielsson, Marie Kannius‐Janson, Junmei Miao Jonasson, Gunnar Steineck, Khalil Helou · 2011 · Genes Chromosomes and Cancer
15. Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis
    Yael Aylon, Noa Furth, Giuseppe Mallel, G. Friedlander, N. Nataraj, M. Dong, Ori Hassin, Rawan Zoabi, Benjamin Cohen, V. Drendel et al. · 2022 · Nature Communications
16. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential
    Daria Drobysheva, Brittni Smith, Maria McDowell, Katrin P. Guillen, H. Atakan Ekiz, Bryan E. Welm · 2015 · Breast Cancer Research
17. Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer
    Shahin Assefnia, Keunsoo Kang, Svenja Groeneveld, Daisuke Yamaji, Sarah A. Dabydeen, Ahmad M. Alamri, Xuefeng Liu, Lothar G. Hennighausen, Priscilla A. Furth · 2014 · Endocrine Related Cancer
18. Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
    Rania Chehade, Rachael Pettapiece-Phillips, Leonardo Salmena, Max Kotlyar, Igor Jurišica, Steven Alexander Narod, Mohammad Reza Akbari, Joanne Kotsopoulos · 2016 · Breast Cancer Research
19. BRCA1‐associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling
    Marieke van de Ven, Xiaoling Liu, Eline van der Burg, Sjoerd Klarenbeek, Xanthippi Alexi, Wilbert T. Zwart, Fred A. Dijcks, Peter Bouwman, Jos Jonkers · 2018 · The Journal of Pathology
20. A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
    Yan Qiu, Liya Wang, Xiaorong Zhong, Li Li, Fei Chen, Xiao Lin, Fangyu Liu, Bo Fu, Hong Yu Zheng, Feng Ye et al. · 2019 · BMC Cancer
21. Overexpression of IGF-1 During Early Development Expands the Number of Mammary Stem Cells and Primes them for Transformation
    Linjie Luo, Andres Santos, Kranti Konganti, Andrew Hillhouse, Isabel U. Lambertz, Yuanning Zheng, Ramesh T. Gunaratna, David W. Threadgill, Robin Fuchs‐Young · 2022 · Stem Cells
22. Tumor suppressor control of the cancer stem cell niche
    Kristin M. Kramer, J Wu, David L. Crowe · 2015 · Oncogene
23. Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice
    Jolien S. de Groot, P. J. van Diest, Miranda van Amersfoort, Eva J. Vlug, Xiaojuan Pan, Natalie D. ter Hoeve, Hilde Rosing, Jos H. Beijnen, Sameh A. Youssef, Alain de Bruin et al. · 2017 · Oncotarget
24. Multipotent PI-MECs are the true targets of MMTV-neu tumorigenesis
    K-U Wagner, Brian W. Booth, Corinne A. Boulanger, Gilbert H. Smith · 2012 · Oncogene
25. Activation Versus Inhibition of IGF1R: A Dual Role in Breast Tumorigenesis
    Joseph J. Bulatowicz, Teresa L. Wood · 2022 · Frontiers in Endocrinology
26. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion
    Marisa M. Faraldo, Mathilde Romagnoli, Loane Wallon, Pierre R. Dubus, Marie‐Ange Deugnier, Silvia Fré · 2024 · Breast Cancer Research
27. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance
    Charly Jehanno, Tamara Fernández-Calero, Denis Habauzit, Stéphane Avner, Frédéric Percevault, Emmanuelle Jullion, Pascale Le Goff, Marie‐May Coissieux, Simone E. Muenst, Mónica Marı́n et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
28. Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity
    Mayra Cecilia Suárez-Arriaga, Alfonso Méndez-Tenorio, Vadim Pérez‐Koldenkova, Ezequiel M. Fuentes‐Pananá · 2021 · Cancers
29. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
    Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti, Haifa Bichiou, Carolina Reduzzi, Dorra Aissaoui, Naziha Ben Hamida, Emilie Agavnian, Najet Srairi‐Abid, Marc Lopez et al. · 2022 · Cells
30. Triple‐negative breast cancer: making the most of a misnomer
    Nicole Jean McCarthy, Gillian Mitchell, Michael Bilous, Nicholas R. C. Wilcken, Geoffrey John Lindeman · 2012 · Asia-Pacific Journal of Clinical Oncology
31. Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells
    Kazuharu Kai, Takayuki Iwamoto, Takashi Kobayashi, Yoshimi Arima, Yayoi Takamoto, Nobuhiko Ohnishi, Chandra Bartholomeusz, Rie Horii, Futoshi Akiyama, Gabriel N. Hortobágyi et al. · 2013 · Oncogene
32. New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours
    Richard D Iggo · 2011 · Breast Cancer Research
33. High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
    Rebecca L. Johnston, Leesa F. Wockner, Amy E. McCart Reed, Adrian P. Wiegmans, Georgia Chenevix‐Trench, Kum Kum Khanna, Sunil R. Lakhani, Chanel Elisha Smart · 2016 · Breast Cancer Research
34. Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line
    Zhijing Tan, Song Nie, Sean McDermott, Max S. Wicha, David M. Lubman · 2017 · Journal of Proteome Research
35. Expression of Luminal Progenitor Marker CD117 in the Human Breast Gland
    Jiyoung Kim, René Villadsen · 2018 · Journal of Histochemistry & Cytochemistry
36. Partial acquisition of stemness properties in tumorspheres obtained from interleukin-8-treated MCF-7 cells
    Natalia Ospina-Muñoz, Jean‐Paul Vernot · 2020 · Tumor Biology
37. Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions
    Agostina Nardone, Sara Corvigno, Annalisa Brescia, Daniel D’Andrea, Gennaro Limite, Bianca Maria Veneziani · 2010 · Cytotechnology
38. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters?
    Lilla Madaras, Nora Balint, Balázs Győrffy, Anna‐Mária Tõkés, Iris Barshack, Ady Yosepovich, Eitan Friedman, Shani Paluch–Shimon, Douglas B. Zippel, Kornélia Baghy et al. · 2015 · Pathobiology
39. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice
    Zhikun Ma, Amanda B. Parris, Zhengzheng Xiao, Erin W. Howard, Stanley D. Kosanke, Xiaoshan Feng, Xiaohe Yang · 2017 · Journal of Experimental & Clinical Cancer Research
40. Dietary polyunsaturated fatty acids modulate adipose secretome and is associated with changes in mammary epithelial stem cell self-renewal
    Evan M. Hill, Raymond M. Esper, Ananda Sen, Becky R. Simon, Muhammad N. Aslam, Yan Jiang, Michael K. Dame, Shannon D. McClintock, Justin A. Colacino, Zora Djurić et al. · 2019 · The Journal of Nutritional Biochemistry
41. Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization
    Nir Ben‐Chetrit, Xiang Niu, Jesus Sotelo, Ariel D. Swett, Vinagolu K. Rajasekhar, Maria S. Jiao, Caitlin M. Stewart, Priya Bhardwaj, Sanjay Kottapalli, Saravanan Ganesan et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
42. Anti-progestin therapy targets hallmarks of breast cancer risk
    Bruno M. Simões, Robert Pedley, Curtis W. McCloskey, Matthew G. Roberts, Austin D. Reed, Alecia‐Jane Twigger, Pirashaanthy Tharmapalan, Amanda Caruso, Sara Cabral, Anthony J. Wilby et al. · 2025 · Nature
43. Unpaved roads: How the DNA damage response navigates endogenous genotoxins
    Vaughn Thada, Roger A. Greenberg · 2022 · DNA repair
44. Identification of a minority population of LMO2 + breast cancer cells that integrate into the vasculature and initiate metastasis
    Shaheen S. Sikandar, Gunsagar Singh Gulati, Jane Antony, Isobel J. Fetter, Angera H. Kuo, William Hai Dang Ho, Veronica Haro Acosta, Soumyashree Das, Chloé Beate Steen, Thiago Almeida Pereira et al. · 2022 · Science Advances
45. Dietary intake of polycyclic aromatic hydrocarbons (PAHs) and breast cancer risk: Evidence from the French E3N-Generations prospective cohort
    Amina Amadou, Delphine Praud, Chloé Marques, Hwayoung Noh, Pauline Frénoy, Arnaud M. Vigneron, Thomas Coudon, Floriane Deygas, Gianluca Severi, Béatrice Fervers et al. · 2025 · Environment International
46. BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells
    Heidi N. Hilton, L. J. Patterson McDonald, N. Santucci, F. R. van der Bent, Audrey Silvestri, J. Dinny Graham, Christine L. Clarke · 2019 · Journal of Mammary Gland Biology and Neoplasia
47. Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes
    Oukseub Lee, Maarten C. Bosland, Minhua Wang, Ali Shidfar, Omid Hosseini, Xiaoling Xuei, Priyam A. Patel, Matthew John Schipma, Irene Helenowski, Julie J. Kim et al. · 2021 · Cancer Letters
48. Acquisition, processing, and single-cell analysis of normal human breast tissues from a biobank
    Poornima Bhat‐Nakshatri, Natascia Marino, Hongyu Gao, Yunlong Liu, Anna Maria Storniolo, Harikrishna Nakshatri · 2021 · STAR Protocols
49. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability
    Fei Liu, Qianying Han, Ting Zhang, Fen Chang, Jingcheng Deng, Xiaotian Huang, Weiping Wang, Yongjie Xu, Qin Li, Luzheng Xu et al. · 2022 · International Journal of Biological Sciences
50. Fate decisions of breast cancer stem cells in cancer progression
    Hui Xu, Fengxia Zhang, Xiaokang Gao, Qiwang Zhou, Linhai Zhu · 2022 · Frontiers in Oncology
51. ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen
    Rifat Ara Najnin, Md Rasel Al Mahmud, Md Maminur Rahman, Shunichi Takeda, Hiroyuki Sasanuma, Hisashi Tanaka, Yasuhiro Murakawa, Naoto Shimizu, Salma Akter, Masatoshi Takagi et al. · 2022 · Cell Reports
52. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9
    Yosuke Yamada, Ronald Simon, Kosuke Iwane, Yuki Nakanishi, Yasuhide Takeuchi, Akihiko Yoshizawa, Masahiro Takada, Masakazu Toi, Hironori Haga, Alexander Marx et al. · 2023 · BMC Cancer
53. Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells
    Robert D. Cardiff, Suzana S. Couto, Brad N. Bolon · 2011 · Breast Cancer Research
54. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer.
    Jacob P. S. Johnson, Prashant Kumar, Miroslav Koulnis, Milan Patel, Karl J. Simin · 2014 · PubMed
55. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions.
    Bharathi Ramdass, Rohit Duggal, Boris Minev, Abhay Shadashiv Chowdhary, Prasad S Koka · 2013 · PubMed
56. Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast
    Werner Boecker, Göran Stenman, Tina Schroeder, Udo Schumacher, Thomas Loening, Lisa Stahnke, Catharina Löhnert, Robert Michael Siering, Arthur Kuper, Vera E. Samoilova et al. · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
57. Unraveling Heterogeneity in Epithelial Cell Fates of the Mammary Gland and Breast Cancer
    Alexandr J. Samocha, Hanna M. Doh, Kai Kessenbrock, Jeroen P. Roose · 2019 · Cancers
58. A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors
    Olof Gerdur Isberg, Ji Young Kim, Agla J. Fridriksdottir, Mikkel Morsing, Vera Timmermans Wielenga, Lone Rønnov‐Jessen, OLE WILLIAM PETERSEN, René Villadsen · 2019 · Scientific Reports
59. Dietary suppression of the mammary CD29hiCD24+ epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice
    Omar M. Rahal, Heather L. Machado, Maria Theresa E. Montales, John Mark P. Pabona, Melissa E. Heard, Shanmugam Nagarajan, Rosalia C. M. Simmen · 2013 · Stem Cell Research
60. Cell of Origin of Breast Cancer: An Updated Hypothesis Merging Epidemiological Data with Molecular Biology
    Hakan Lars Olsson · 2013 · Journal of Carcinogenesis & Mutagenesis
61. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis.
    Takefumi Furuya, Isao Matsumoto, Naoyuki Tsuchiya, Masayuki Hakoda, Naomi Ichikawa, Toru Yago, K Higami, Yuki Nanke, Takayuki Sumida, Naoyuki Kamatani et al. · 2008 · PubMed
62. EZH2 takes the stage when BRCA1 loses
    Lan Wang, Haojie Huang · 2013 · Cell Cycle
63. Single cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype
    Fátima Valdés‐Mora, Robert Salomon, Brian Gloss, Andrew M. K. Law, Lesley E. Castillo, Kendelle Joan Murphy, Jeron Venhuizen, Astrid Magenau, Michael Papanicolau, Laura Rodríguez de la Fuente et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
64. Epigenetic changes with age primes mammary luminal epithelia for cancer initiation
    Rosalyn W. Sayaman, Masaru Miyano, Parijat Senapati, Sundus Shalabi, Arrianna Zirbes, Michael E. Todhunter, Victoria L. Seewaldt, Susan L. Neuhausen, Martha R. Stampfer, Dustin E. Schones et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
65. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
    Hye‐Yeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, Curtis W. McCloskey, Abhijith Kuttanamkuzhi, Barbara T. Grünwald, Luís Palomero, Mathepan Jeya Mahendralingam, Matthew Waas, Arvind Singh Mer et al. · 2023 · Cell Reports
66. Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants
    Zhenzhen Zhang, Shangyuan Ye, Sarah Margaret Bernhardt, Heidi D Nelson, Ellen M. Velie, Virginia F. Borges, Emma Roisin Woodward, D. Gareth Evans, Pepper J. Schedin · 2024 · JAMA Network Open
67. Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer
    Francesca Pia Carbone, Pietro Ancona, Stefano Volinia, Anna Terrazzan, Nicoletta Bianchi · 2025 · Biology
68. Distinct Effects of Adipose-Derived Stem Cells and Adipocytes on Normal and Cancer Cell Hierarchy
    Manjushree Anjanappa, Riesa M. Burnett, Michael A. J. Zieger, Stephanie Merfeld‐Clauss, William A. Wooden, Keith L. March, Sunil S. Tholpady, Harikrishna Nakshatri · 2016 · Molecular Cancer Research
69. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
    Charlotte Rypens, François Bertucci, Pascal Finetti, Fredika M. Robertson, Sandra Viviana Fernandez, Naoto Tada Ueno, Wendy A. Woodward, Kenneth van Golen, Peter B. Vermeulen, Luc Yves Dirix et al. · 2022 · npj Breast Cancer
70. Breast Cancer Updates
    Selim Sözen, Seyfi Emir · 2022 · IntechOpen eBooks
71. Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway
    Ji Ma, Yuqing Gong, Xiaoran Sun, C R Liu, Xueying Li, Yi Sun, Decao Yang, Junming He, Mengyuan Wang, Juan Du et al. · 2024 · Science Advances
72. R-loop functions in Brca1 -associated mammary tumorigenesis
    Huai-Chin Chiang, Leilei Qi, Payal Mitra, Yimeng Huang, Yanfen Hu, Rong Li · 2024 · Proceedings of the National Academy of Sciences
73. Prostate cancer stem cells: The case for model systems
    Kathleen Kelly, Paul G. Hynes · 2012 · Journal of Carcinogenesis
74. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast
    Trine Tramm, Jee-Yeon Kim, Sebastian Leibl, Farid Moinfar, Fattaneh A. Tavassoli · 2016 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
75. Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
    Mafalda Laranjo, Maria João Carvalho, Beatriz Serambeque, André Alves, Carlos Miguel Marto, Isabel Silva, Artur Augusto Paiva, Maria Filomena Botelho · 2020 · Journal of Visualized Experiments
76. Contributions of Yap and Taz dysfunction to breast cancer initiation, progression, and aging‐related susceptibility
    Tara Fresques, Mark A. LaBarge · 2020 · Aging and Cancer
77. Bidirectional Regulatory Cross-Talk between Cell Context and Genomic Aberrations Shapes Breast Tumorigenesis
    Brijesh Kumar, Poornima Bhat‐Nakshatri, Calli Maguire, Max Henry Jacobsen, Constance J. Temm, George Earl Sandusky, Harikrishna Nakshatri · 2021 · Molecular Cancer Research
78. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
    Michael A. Cantrell, Nancy D. Ebelt, Adam D. Pfefferle, Charles M. Perou, Carla L. Van Den Berg · 2015 · Oncotarget
79. Stem Cells and Cancer Stem Cells
    Phuc Van Pham · 2015 · SpringerBriefs in stem cells
80. Overview
    Maider Zabala, Neethan A. Lobo, Dalong Qian, Linda J. van Weele, Diane Heiser, Michael F. Clarke · 2016 · Elsevier eBooks
81. LPA receptor activity is basal specific and coincident with early pregnancy and involution during mammary gland postnatal development
    Deanna Acosta, Susmita Bagchi, Pilib Ó Broin, Daniel P. Hollern, Silvia E. Racedo, Bernice E. Morrow, Rani S. Sellers, John M. Greally, Aaron Golden, Eran R. Andrechek et al. · 2016 · Scientific Reports
82. Tumor Heterogeneity
    John W. Cassidy, Alejandra Bruna · 2017 · Elsevier eBooks
83. Wnt signaling and mammary stem cells
    Caroline M. Alexander · 2021 · Vitamins and hormones
84. Xenotransplantation of Breast Cancers
    Massimiliano Cariati, Rebecca Marlow, Gabriela Dontu · 2011 · Methods in molecular biology
85. Breast cancer risk in BRCA1 mutation carriers: insight from mouse models
    Mary Helen Barcellos‐Hoff, David L. Kleinberg · 2013 · Annals of Oncology
86. Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models
    Maria Lambouras, Charlotte Roelofs, Melrine Pereira, Emily Gruber, Jessica L. Vieusseux, Patrick Lanteri, Cameron N. Johnstone, Fenella Muntz, Sandra A O'Toole, Lisa M. Ooms et al. · 2023 · International Journal of Molecular Sciences
87. Single-cell and spatial analyses reveal a tradeoff between murine mammary proliferation and lineage programs associated with endocrine cues
    G. Kenneth Gray, Nomeda Girnius, Hendrik J. Kuiken, Aylin Z. Henstridge, Joan S. Brugge · 2023 · Cell Reports
88. Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium
    Matthew Waas, Amanda Khoo, Pirashaanthy Tharmapalan, Curtis W. McCloskey, Meinusha Govindarajan, Bowen Zhang, Shahbaz Khan, Paul D. Waterhouse, Rama Khokha, Thomas Kislinger · 2024 · Cell Reports Methods
89. RANK/RANKL Signaling Pathway in Breast Development and Cancer
    Gema Pérez-Chacón, Patricia G. Santamarı́a, Jaime Redondo-Pedraza, Eva González‐Suárez · 2025 · Advances in experimental medicine and biology
90. Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer
    Yijia Hua, Ningjun Duan, Chunxiao Sun, Fan Yang, Min Tian, Yanting Sun, Shuhan Zhao, Jue Gong, Qian Liu, Xiang Huang et al. · 2025 · eLife
91. Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1 / 2 Mutation Carriers
    Anthony Caputo, Kavya Vipparthi, Peter S. Bazeley, Erinn Downs, Patrick J. McIntire, Lauren Ashley Duckworth, Ying Ni, Bo Hu, Ruth A. Keri, Mihriban Karaayvaz · 2023 · Molecular Cancer Research
92. Single cell approaches to understand environmental impacts on aggressive breast cancers
    David Aguilar Jr., Justin A. Colacino · 2024 · Current Opinion in Toxicology
93. Antiprogestins for breast cancer treatment: We are almost ready
    Andres M. Elia, Gabriela Pataccini, Leo Saldain, Luisa Ambrosio, Claudia Lanari, Paola Rojas · 2024 · The Journal of Steroid Biochemistry and Molecular Biology
94. Chromosomal instability as an architect of the cancer stemness landscape
    Shahnawaz Ahmad Baba, Aran Zakeri, Jay S. Desgrosellier · 2024 · Frontiers in Cell and Developmental Biology
95. Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesis
    Caleb A. Dawson, Michael J. G. Milevskiy, Bianca D. Capaldo, Raymond K. H. Yip, Xiaoyu Song, François Vaillant, Lexie Prokopuk, Felicity C. Jackling, Gordon K. Smyth, Yunshun Chen et al. · 2024 · Cell Reports
96. A hybrid epithelial-mesenchymal transition program enables basal epithelial cells to bypass stress-induced stasis and contributes to a metaplastic breast cancer progenitor state
    Joseph A. Caruso, Chira Chen‐Tanyolac, Thea Dorothy Tlsty · 2024 · Breast Cancer Research
97. Breast Cancer Stem Cells
    Fengyan Yu, Qiang Liu, Yujie Liu, Jieqiong Liu, Erwei Song · 2011 · InTech eBooks
98. Cancer stem cells and cells of origin in MMTV-Her2/neu-induced mammary tumorigenesis
    P-K Lo, Hexin Chen · 2012 · Oncogene
99. Aging phenotypes in cultured normal human mammary epithelial cells are correlated with decreased telomerase activity independent of telomere length
    Klara Sputova, James C. Garbe, Fanny A. Pelissier, Eric K. Chang, Martha R. Stampfer, Mark A. LaBarge · 2013 · Genome Integrity
100. 184AA3: a xenograft model of ER+ breast adenocarcinoma
     William Curtis Hines, Irene Kuhn, Kate Thi, Berbie M. Chu, Gaelen Britton Stanford‐Moore, Rocío G. Sampayo, James C. Garbe, Martha R. Stampfer, Alexander D. Borowsky, Mina J. Bissell · 2015 · Breast Cancer Research and Treatment